Lignan glycosides from Fritillaria verticillata Willd. and their anti-inflammatory activities.


Journal

Fitoterapia
ISSN: 1873-6971
Titre abrégé: Fitoterapia
Pays: Netherlands
ID NLM: 16930290R

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 21 03 2023
revised: 21 05 2023
accepted: 25 05 2023
medline: 21 6 2023
pubmed: 1 6 2023
entrez: 31 5 2023
Statut: ppublish

Résumé

Three undescribed lignan glycosides, echiunines E-G (1-3), as well as eight known compounds (4-11) were isolated from Fritillaria verticillata Willd. Among them, compounds 1-3 were a series of lignan glycosides reported for the first time from genus Fritillaria. Their structures were elucidated by analyses of extensive spectroscopic data and comparison of the NMR data with those reported previously, the absolute configuration of compounds were further confirmed by calculated ECD method. The NO release inhibitory effects of compounds were evaluated in LPS-activated RAW264.7 macrophages. Compounds 7-8 showed inhibitory acitivities in a dose-dependent manner.

Identifiants

pubmed: 37257697
pii: S0367-326X(23)00128-4
doi: 10.1016/j.fitote.2023.105553
pii:
doi:

Substances chimiques

Lignans 0
Glycosides 0
Anti-Inflammatory Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105553

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Nan Ma (N)

Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, HarBin Medical University, HarBin 150081, People's Republic of China.

Si-Xuan Liu (SX)

Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, HarBin Medical University, HarBin 150081, People's Republic of China.

Yong-Fu Li (YF)

Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, HarBin Medical University, HarBin 150081, People's Republic of China.

Fu-Hua Deng (FH)

Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, HarBin Medical University, HarBin 150081, People's Republic of China.

Yi-Hui Yang (YH)

Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, HarBin Medical University, HarBin 150081, People's Republic of China.

Chang Li (C)

Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, HarBin Medical University, HarBin 150081, People's Republic of China; Key Laboratory of Gut Microbiota and Pharmacogenomics of Heilongjiang Province, College of Pharmacy, HarBin Medical University, HarBin 150081, People's Republic of China. Electronic address: lichang661@126.com.

Yue-Hu Pei (YH)

Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, HarBin Medical University, HarBin 150081, People's Republic of China. Electronic address: peiyueh@vip.163.com.

Articles similaires

Yu Hu, Liu-Lin Chen, Zhen Ye et al.
1.00
Colitis, Ulcerative Humans Animals Drugs, Chinese Herbal Anti-Inflammatory Agents
Animals Acetylcysteine Antioxidants Rats, Wistar Rats

Expanding the antiprotozoal activity and the mechanism of action of n-butyl and iso-butyl ester of quinoxaline-1,4-di-

Alonzo González-González, Oscar Sánchez-Sánchez, Lilián Yépez-Mulia et al.
1.00
Giardia lamblia Trichomonas vaginalis Entamoeba histolytica Antiprotozoal Agents Quinoxalines
Lactobacillus plantarum Antioxidants Egypt Anti-Inflammatory Agents Humans

Classifications MeSH